Skip to main content
Log in

Senile dementia of the Alzheimer type treated with aniracetam: a new nootropic agent

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Forty-four patients with senile dementia of the Alzheimer type were randomly allocated into double-blind treatment with either aniracetam (RO 13-5057) 1 g or placebo daily for 3 months. Neurological examinations were made before and after treatment and psychometric tests were performed before and after 1 month's and after 3 month's treatment. Treatment was interrupted due to occurrence of confusion in four cases in the aniracetam group and in one case in the placebo group. During treatment, an improvement was seen in several cognitive tests, especially those associated with memory, but this improvement occurred in the placebo as well as in the aniracetam-treated group. In clinical evaluation no difference was seen in efficacy between the two treatment groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Benton P (1963) The revised visual retention test. The Psychological Corporation, New York

    Google Scholar 

  • Canter GJ, La Torre R de, Mier M (1961) A method for evaluating disability in patients with Parkinson's disease. J Nerv Ment Dis 133:143–147

    Google Scholar 

  • Christensen AL (1974) Luria's Neuropsychological Investigation. Munksgaard, Copenhagen

    Google Scholar 

  • Dajas F, Romero S, Florens M, Lorenzo J et al. (1983) Neuropsychological and psychiatric assessment of the effects of aniracetam (RO 13-5057) on age related brain deficits. Preliminary results. Presented at the 6th Int Neuropsychological Soc (INS) Eur Conf, Lisbon, 14–17 June, 1983. The InS Bulletin, p 12

  • Giurgea C, Lefevre D, Lercrenier C, David-Remade M (1971) Pharmacological protection against hypoxia-induced amnesia in rats. Psychopharmacologica 20:160–168

    Google Scholar 

  • Hachinski VC, Iliff LD, Zilkha E, Du Bowlay GH, McAllister VL, Marshall J, Ross-Russell RW, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32:632–637

    Google Scholar 

  • Jarho L (1973) Korsakoff-like amnesic syndrome in penetrating brain injury. A study of Finnish war veterans. Acta Neurol Scand 49:Suppl 54

  • Lagergren K, Levander S (1974) A double-blind study on the effects of piracetam upon perceptual + psychomotor performance at varied heart rates in patients with artificial pace-makers. Psychopharmacologica 39:97–104

    Google Scholar 

  • Lezak MD (1976) Neuropsychological Assessment. O.U.P., New York

    Google Scholar 

  • Loew DM, Weil C (1982) Hydergine in senile mental impairment. Gerontology 28:54–74

    Google Scholar 

  • Portin R, Rinne UK (1980) Neuropsychological responses of parkinsonian patients to long-term levodopa treatment. In: Rinne UK, Kingler M, Stamm G (eds) Parkinson's disease — current progress, problems and management. Elsevier, North Holland Biomedical Press, pp 271–304

  • Portin R, Rinne UK (1983) The effect of deprenyl on cognition and emotion in parkinsonian patients with long-term levodopa treatment. Acta Neurol Scand 68:Suppl 95; 135–144

    Google Scholar 

  • Rinne UK, Sonninen V (1968) A double-blind study ofl-dopa treatment in Parkinson's disease. Eur Neurol 1:180–191

    Google Scholar 

  • Saletu B, Grunberger J, Linzmayer L (1980) Quantitative EEG and psychometric analyses in assessing CNS-activity of Ro 13-5057 — a cerebral insufficiency improver. Methods Find Exp Clin Pharmacol 2(5):269–285

    Google Scholar 

  • Shader RJ, Harmatz JS, Salzman C (1974) A new scale for clinical assessments in geriatric populations. Sandoz clinical assessment geriatric (SCAG). J Am Geriatr Soc 22:107–113

    Google Scholar 

  • Wechsler D (1981) Wechsler Adult Intelligence Scale — revised. The Psychological Corporation, New York

    Google Scholar 

  • Wells PL, Reusch J (1945) Mental examiner's handbook. Revised edition. The Psychological Corporation, New York

    Google Scholar 

  • Wolthuis OL (1971) Experiments with UCB 6125, a drug which enhances acquisition in rats. Its effects compared with those of metanphetamine. Eur J Pharmacol 16:283–297

    Google Scholar 

  • Zung WWK (1965) A self-rating depression scale. Arch Gen Psychiatry 12:63–70

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sourander, L.B., Portin, R., Mölsä, P. et al. Senile dementia of the Alzheimer type treated with aniracetam: a new nootropic agent. Psychopharmacologia 91, 90–95 (1987). https://doi.org/10.1007/BF00690933

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00690933

Key words

Navigation